{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:22:43Z","timestamp":1790252563178,"version":"4.1.0"},"reference-count":29,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2018,9,1]]},"DOI":"10.1536\/ihj.17-461","type":"journal-article","created":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T22:39:41Z","timestamp":1535495981000},"page":"1174-1179","source":"Crossref","is-referenced-by-count":34,"title":["Aortic Dissection and Cardiac Dysfunction Emerged Coincidentally During the Long-Term Treatment with Angiogenesis Inhibitors for Metastatic Renal Cell Carcinoma"],"prefix":"10.1536","volume":"59","author":[{"given":"Midori","family":"Takada","sequence":"first","affiliation":[{"name":"Department of Onco-Cardiology, Osaka International Cancer Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taku","family":"Yasui","sequence":"additional","affiliation":[{"name":"Department of Onco-Cardiology, Osaka International Cancer Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Oka","sequence":"additional","affiliation":[{"name":"Department of Medical Checkup, Osaka International Cancer Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wataru","family":"Shioyama","sequence":"additional","affiliation":[{"name":"Department of Onco-Cardiology, Osaka International Cancer Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Kuroda","sequence":"additional","affiliation":[{"name":"Department of Onco-Cardiology, Osaka International Cancer Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasutomo","family":"Nakai","sequence":"additional","affiliation":[{"name":"Department of Urology, Osaka International Cancer Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Nishimura","sequence":"additional","affiliation":[{"name":"Department of Urology, Osaka International Cancer Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikio","family":"Mukai","sequence":"additional","affiliation":[{"name":"Department of Medical Checkup, Osaka International Cancer Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Fujita","sequence":"additional","affiliation":[{"name":"Department of Onco-Cardiology, Osaka International Cancer Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Oka T, Akazawa H, Naito AT, Komuro I. Angiogenesis and cardiac hypertrophy: maintenance of cardiac function and causative roles in heart failure. Circ Res 2014; 114: 565-71.","DOI":"10.1161\/CIRCRESAHA.114.300507"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Ivy SP, Wick JY, Kaufman BM. An overview of small-molecule inhibitors of VEGFR signaling. Nat Rev Clin Oncol 2009; 6: 569-79.","DOI":"10.1038\/nrclinonc.2009.130"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Oshima Y, Tanimoto T, Yuji K, Tojo A. Association between aortic dissection and systemic exposure of vascular endothelial growth factor pathway inhibitors in the Japanese Adverse Drug Event Report Database. Circulation 2017; 135: 815-7.","DOI":"10.1161\/CIRCULATIONAHA.116.025144"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Henry TD, Annex BH, McKendall GR, <i>et al<\/i>. The VIVA trial: Vascular endothelial growth factor in Ischemia for Vascular Angiogenesis. Circulation 2003; 107: 1359-65.","DOI":"10.1161\/01.CIR.0000061911.47710.8A"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Ku DD, Zaleski JK, Liu S, Brock TA. Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries. Am J Physiol 1993; 265: H586-92.","DOI":"10.1152\/ajpheart.1993.265.2.H586"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Ferrara N. Vascular endothelial growth factor as a target for anticancer therapy. Oncologist 2004; 9: 2-10.","DOI":"10.1634\/theoncologist.9-suppl_1-2"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Facemire CS, Nixon AB, Griffiths R, Hurwitz H, Coffman TM. Vascular endothelial growth factor receptor 2 controls blood pressure by regulating nitric oxide synthase expression. Hypertension 2009; 54: 652-8.","DOI":"10.1161\/HYPERTENSIONAHA.109.129973"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Steeghs N, Rabelink TJ, Op&apos;t Roodt J, <i>et al<\/i>. Reversibility of capillary density after discontinuation of bevacizumab treatment. Ann Oncol 2010; 21: 1100-5.","DOI":"10.1093\/annonc\/mdp417"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Steeghs N, Gelderblom H, Roodt JO, <i>et al<\/i>. Hypertension and rarefaction during treatment with telatinib, a small molecule angiogenesis inhibitor. Clin Cancer Res 2008; 14: 3470-6.","DOI":"10.1158\/1078-0432.CCR-07-5050"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Mourad JJ, des Guetz G, Debbabi H, Levy BI. Blood pressure rise following angiogenesis inhibition by bevacizumab. A crucial role for microcirculation. Ann Oncol 2008; 19: 927-34.","DOI":"10.1093\/annonc\/mdm550"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Shiga T. Cardiac troponin as a specific and non-specific biomarker for cardiovascular events. Int Heart J 2016; 57: 265-7.","DOI":"10.1536\/ihj.16-145"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Plana JC, Galderisi M, Barac A, <i>et al<\/i>. Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 2014; 15: 1063-93.","DOI":"10.1093\/ehjci\/jeu192"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Plana JC, Galderisi M, Barac A, <i>et al<\/i>. Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 2014; 27: 911-39.","DOI":"10.1016\/j.echo.2014.07.012"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14. Ferrara N, Carver-Moore K, Chen H, <i>et al<\/i>. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 1996; 380: 439-42.","DOI":"10.1038\/380439a0"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15. Carmeliet P, Ferreira V, Breier G, <i>et al<\/i>. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 1996; 380: 435-9.","DOI":"10.1038\/380435a0"},{"key":"16","doi-asserted-by":"publisher","unstructured":"16. Shalaby F, Rossant J, Yamaguchi TP, <i>et al<\/i>. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 1995; 376: 62-6.","DOI":"10.1038\/376062a0"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Heineke J, Auger-Messier M, Xu J, <i>et al<\/i>. Cardiomyocyte GATA4 functions as a stress-responsive regulator of angiogenesis in the murine heart. J Clin Invest 2007; 117: 3198-210.","DOI":"10.1172\/JCI32573"},{"key":"18","doi-asserted-by":"publisher","unstructured":"18. Sano M, Minamino T, Toko H, <i>et al<\/i>. p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload. Nature 2007; 446: 444-8.","DOI":"10.1038\/nature05602"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Formiga MN, Fanelli MF. Aortic dissection during antiangiogenic therapy with sunitinib. A case report. Sao Paulo Med J 2015; 133: 275-7.","DOI":"10.1590\/1516-3180.2013.7380002"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Funahashi Y, Sassa N, Inada-Inoue M, Ando Y, Matsukawa Y, Gotoh M. Acute aortic dissection in a patient receiving multiple tyrosine kinase inhibitors for 5 years. Aktuel Urol 2014; 45: 132-4.","DOI":"10.1055\/s-0033-1363274"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Edeline J, Laguerre B, Rolland Y, Patard JJ. Aortic dissection in a patient treated by sunitinib for metastatic renal cell carcinoma. Ann Oncol 2010; 21: 186-7.","DOI":"10.1093\/annonc\/mdp480"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Serrano C, Su\u00e1rez C, Andreu J, Carles J. Acute aortic dissection during sorafenib-containing therapy. Ann Oncol 2010; 21: 181-2.","DOI":"10.1093\/annonc\/mdp468"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Niwa N, Nishiyama T, Ozu C, Yagi Y, Saito S. Acute aortic dissection in a patient with metastatic renal cell carcinoma treated with axitinib. Acta Oncol 2015; 54: 561-2.","DOI":"10.3109\/0284186X.2014.963887"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Katoh M, Takeda N, Arimoto T, <i>et al<\/i>. Bevacizumab-related microvascular angina and its management with nicorandil. Int Heart J 2017; 58: 803-5.","DOI":"10.1536\/ihj.16-537"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Spronck B, Delhaas T, De Lepper AG, <i>et al<\/i>. Patient-specific blood pressure correction technique for arterial stiffness: evaluation in a cohort on anti-angiogenic medication. Hypertens Res 2017; 40: 752-7.","DOI":"10.1038\/hr.2017.32"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Mulligan-Kehoe MJ. The vasa vasorum in diseased and nondiseased arteries. Am J Physiol Heart Circ Physiol 2010; 298: H295-305.","DOI":"10.1152\/ajpheart.00884.2009"},{"key":"27","unstructured":"27. Couffinhal T, Kearney M, Witzenbichler B, <i>et al<\/i>. Vascular endothelial growth factor\/vascular permeability factor (VEGF\/VPF) in normal and atherosclerotic human arteries. Am J Pathol 1997; 150: 1673-85."},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Shen YH, Zhang L, Ren P, <i>et al<\/i>. AKT2 confers protection against aortic aneurysms and dissections. Circ Res 2013; 112: 618-32.","DOI":"10.1161\/CIRCRESAHA.112.300735"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Kurihara T, Shimizu-Hirota R, Shimoda M, <i>et al<\/i>. Neutrophil-derived matrix metalloproteinase 9 triggers acute aortic dissection. Circulation 2012; 126: 3070-80.","DOI":"10.1161\/CIRCULATIONAHA.112.097097"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/59\/5\/59_17-461\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T03:46:51Z","timestamp":1571802411000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/59\/5\/59_17-461\/_article"}},"subtitle":["A Case Report of Onco-Cardiology"],"short-title":[],"issued":{"date-parts":[[2018,9,1]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.17-461","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,1]]}}}